{"id":"NCT03697109","sponsor":"Corcept Therapeutics","briefTitle":"A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome","officialTitle":"Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-15","primaryCompletion":"2024-04-08","completion":"2024-04-15","firstPosted":"2018-10-05","resultsPosted":"2025-04-24","lastUpdate":"2025-07-16"},"enrollment":152,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Cushing Syndrome"],"interventions":[{"type":"DRUG","name":"Relacorilant","otherNames":["CORT125134"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Relacorilant (OL Phase)","type":"EXPERIMENTAL"},{"label":"Relacorilant (RW Phase)","type":"EXPERIMENTAL"},{"label":"Placebo (RW Phase)","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, double-blind, placebo-controlled, randomized-withdrawal study to assess the efficacy, safety and pharmacokinetics (PK) of relacorilant in patients with endogenous Cushing syndrome and concurrent type 2 diabetes mellitus/impaired glucose tolerance (DM/IGT) and/or uncontrolled hypertension (HTN).","primaryOutcome":{"measure":"Number of Patients With Loss of Response With Respect to Hypertension During the RW Phase.","timeFrame":"Week 22 (end of OL Phase) and Week 36 (Week 12 of RW Phase)","effectByArm":[{"arm":"Relacorilant (RW Phase)","deltaMin":3,"sd":null},{"arm":"Placebo (RW Phase)","deltaMin":1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0215"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":64,"countries":["United States","Austria","Bulgaria","Canada","Germany","Israel","Italy","Netherlands","Poland","Romania","Spain"]},"refs":{"pmids":["35058882"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":29,"n":152},"commonTop":["Nausea","Oedema peripheral","Back pain","Pain in extremity","Headache"]}}